Highbridge Capital Management’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
Other funds holding GILD
Highbridge Capital Management's GILD Position: Q4 2018 in Review
Highbridge Capital Management sold out of Gilead Sciences (GILD) in Q4 2018, closing a stake of 31,541 shares — an estimated $2.44M sold.
Highbridge Capital Management first reported a position in GILD in Q2 2013 and held it in 18 quarters. The position peaked at $72.4M in Q4 2015. 1,496 funds tracked by Wall St. Rank hold GILD as of Q4 2018.
- Highbridge Capital Management reported no remaining Gilead Sciences position as of Q4 2018 after selling out during the quarter.
- Highbridge Capital Management sold 31,541 Gilead Sciences shares in Q4 2018, an estimated $2.44M.
- Highbridge Capital Management first reported a position in Gilead Sciences in Q2 2013 and held it in 18 quarters.
- Highbridge Capital Management's Gilead Sciences position peaked at $72.4M in Q4 2015.
- 1,496 funds tracked by Wall St. Rank held Gilead Sciences as of Q4 2018.
Based on Highbridge Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.